The Association between High-Dose Allopurinol and Erythropoietin Hyporesponsiveness in Advanced Chronic Kidney Disease: JOINT-KD Study.
Megumi OikawaHiroki NishiwakiTakeshi HasegawaSho SasakiMasahiko YazawaHitoshi MiyazatoYosuke SakaHideaki ShimizuYoshiro FujitaMinoru MurakamiDaisuke UchidaHiroo KawarazakiShinya OmiyaFumihiko SasaiFumihiko Koiwanull nullPublished in: Nephron (2024)
Our study suggests that the use of high-dose allopurinol exceeding the optimal dose may lead to hyporesponsiveness to erythropoiesis-stimulating agents.